| Literature DB >> 23766416 |
Bülent Arman Aksoy1, Jianjiong Gao, Gideon Dresdner, Weiqing Wang, Alex Root, Xiaohong Jing, Ethan Cerami, Chris Sander.
Abstract
MOTIVATION: The interaction between drugs and their targets, often proteins, and between antibodies and their targets, is important for planning and analyzing investigational and therapeutic interventions in many biological systems. Although drug-target and antibody-target datasets are available in separate databases, they are not publicly available in an integrated bioinformatics resource. As medical therapeutics, especially in cancer, increasingly uses targeted drugs and measures their effects on biomolecular profiles, there is an unmet need for a user-friendly toolset that allows researchers to comprehensively and conveniently access and query information about drugs, antibodies and their targets.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23766416 PMCID: PMC3722529 DOI: 10.1093/bioinformatics/btt345
Source DB: PubMed Journal: Bioinformatics ISSN: 1367-4803 Impact factor: 6.937
PiHelper enables integration of 10 publicly available drug-target and drug-antibody resources
| Data resource | Type of data |
|---|---|
| DrugBank ( | Drug-target |
| KEGG Drug ( | Drug-target |
| Drug-target | |
| GDSC ( | Drug-target |
| Drug-target | |
| Cancer.gov | Drug-annotation |
| The Human Protein Atlas ( | Antibody-target |
| Antibody-target | |
| Antibody-target | |
| Pathway Commons ( | Gene-sets |
Note: KEGG, Kyoto Encyclopedia of Genes and Genomes; GDSC, The Genomics of Drug Sensitivity in Cancer
Fig. 1.Sample target network visualization: results showing all drug and antibody associations of EGFR and ERBB2 genes. PiHelper web UI allows exporting the network to various formats, e.g. SVG and Simple Interaction Formats